NEW YORK (Reuters Health) – In patients taking immune checkpoint
Prior treatment may impact efficacy of ACT-TIL in patients with metastatic melanoma
Bottom Line: Patients with metastatic melanoma that had relapsed on
Melanoma registry results shine light on rare pediatric cancer
Pediatric melanoma is a rare disease with only around 400
Why some melanoma patients do not respond to immunotherapy
By harnessing the immune system against cancer, immunotherapies have revolutionized
Novel hydrogel slowly releases RNA nanovaccines to shrink tumors
Messenger RNA (mRNA) vaccines to prevent COVID-19 have made headlines
Methoblastin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons
An epidemic of overdiagnosis: Melanoma diagnoses skyrocket
In a Sounding Board article published in The New England
Large decrease seen in melanoma mortality from 2013 to 2016
(HealthDay)—From 2013 to 2016, there was a large decrease of
One in two patients with metastatic melanoma alive after five years with combination immunotherapy
One in two patients with metastatic melanoma is alive with
Melanoma patient outcomes predicted by computational biology
Walter and Eliza Hall Institute researchers have used computational biology